News | July 19, 2023
PrecisionLife identifies first detailed genetic risk factors for long COVID
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Pheezee is designed to assess musculoskeletal and neuromuscular health.
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Mindset disagrees with and denies the allegations set forth from Reunion.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
Subscribe To Our Newsletter & Stay Updated
